These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8196281)
1. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats. Uriu K; Kaizu K; Hashimoto O; Komine N; Etoh S Kidney Int; 1994 Mar; 45(3):794-802. PubMed ID: 8196281 [TBL] [Abstract][Full Text] [Related]
2. Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat. Uriu K; Kaizu K; Qie YL; Kai K; Eto S J Diabetes Complications; 1999; 13(4):182-6. PubMed ID: 10616856 [TBL] [Abstract][Full Text] [Related]
3. Effects of endothelin receptor blockade on hypervasoreactivity in streptozotocin-diabetic rats: vessel-specific involvement of thromboxane A2. Arikawa E; Cheung C; Sekirov I; Battell ML; Yuen VG; McNeill JH Can J Physiol Pharmacol; 2006; 84(8-9):823-33. PubMed ID: 17111027 [TBL] [Abstract][Full Text] [Related]
4. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy. Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S Nephron; 1990; 56(3):297-305. PubMed ID: 2077412 [TBL] [Abstract][Full Text] [Related]
5. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension. Cediel E; Vázquez-Cruz B; Navarro-Cid J; de las Heras N; Sanz-Rosa D; Cachofeiro V; Lahera V Kidney Int Suppl; 2002 Dec; (82):S2-7. PubMed ID: 12410847 [TBL] [Abstract][Full Text] [Related]
6. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046. Hatziantoniou C; Papanikolaou N Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267 [TBL] [Abstract][Full Text] [Related]
7. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Wilcox CS; Welch WJ; Snellen H Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063 [TBL] [Abstract][Full Text] [Related]
8. Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats. Okumura M; Imanishi M; Okamura M; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Nakatani T; Fujii S Life Sci; 2003 May; 72(24):2695-705. PubMed ID: 12679187 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
11. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor. Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796 [TBL] [Abstract][Full Text] [Related]
12. Reduced glomerular thromboxane receptor sites and vasoconstrictor responses in diabetic rats. Wilkes BM; Kaplan R; Mento PF; Aynedjian HS; Macica CM; Schlondorff D; Bank N Kidney Int; 1992 Apr; 41(4):992-9. PubMed ID: 1387436 [TBL] [Abstract][Full Text] [Related]
13. Effects of thromboxane A2 synthesis inhibition on renal renin release and protein excretion in diabetic rats. Omoto A; Katayama S; Inaba M; Maruno Y; Watanabe T; Kawazu S; Ishii J Nihon Jinzo Gakkai Shi; 1988 Mar; 30(3):305-11. PubMed ID: 3050209 [No Abstract] [Full Text] [Related]
14. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat. Tajiri Y; Umeda F; Inoguchi T; Nawata H J Diabetes Complications; 1994; 8(2):126-32. PubMed ID: 8061349 [TBL] [Abstract][Full Text] [Related]
15. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs. Higo K; Karasawa A Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224 [TBL] [Abstract][Full Text] [Related]
16. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats. Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. Stork JE; Dunn MJ J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644 [TBL] [Abstract][Full Text] [Related]
18. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction. Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396 [TBL] [Abstract][Full Text] [Related]
19. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268 [TBL] [Abstract][Full Text] [Related]
20. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]